Genetic studies yield clues to the pathogenesis of Langerhans cell histiocytosis

Zhang Li, Moss Joel

Source: Eur Respir J 2016; 47:1629-1631
Journal Issue: June

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Zhang Li, Moss Joel. Genetic studies yield clues to the pathogenesis of Langerhans cell histiocytosis. Eur Respir J 2016; 47:1629-1631

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genetic landscape of adult Langerhans cell histiocytosis with lung involvement
Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019
Year: 2020



Genetic landscape of pulmonary langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018

A role for ITPA variants in the clinical course of pulmonary Langerhans' cell histiocytosis?
Source: Eur Respir J 2010; 36: 684-686
Year: 2010



New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170042; 10.1183/16000617.0042-2017
Year: 2017



Lung function progression in Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012


Lack of evidence for the involvement of Merkel cell polyomavirus in pulmonary Langerhans cell histiocytosis
Source: ERJ Open Res, 6 (2) 00230-2019; 10.1183/23120541.00230-2019
Year: 2020



Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019



Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019

Langerhans' cell histiocytosis: clinical and diagnostic features and response to therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 219s
Year: 2001

How I manage pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017
Year: 2017



Langerhans cell histiocytosis: is it an ILD?
Source: Virtual Congress 2021 – Interstitial lung diseases
Year: 2021


Pulmonary Langerhans' cell histiocytosis
Source: Respipedia Article
Year: 2016

Pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

Pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008



Pulmonary Langerhans' cell histiocytosis
Source: Eur Respir Mon; 2009: 46: 155–175
Year: 2009

The proteomic analysis of BAL from patients with langerhans cell histiocytosis (LCH)
Source: Eur Respir J 2007; 30: Suppl. 51, 245s
Year: 2007

Cytokine profiling in Pulmonary Langerhans Cell Histiocytosis: novel insights into pathogenesis.
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018



Paediatric pulmonary Langerhans cell histiocytosis
Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020
Year: 2020



Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019